We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02027168
First Posted: January 6, 2014
Last Update Posted: January 26, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Clear Passage Therapies, Inc
  Purpose
This study will examine the impact of manual physical therapy on endocrine function in women diagnosed as being infertile due to elevated follicle stimulating hormone (FSH) levels (10 mIU/mL or higher) on days 2-5 of their menstrual cycle. It is hypothesized that the manual physical therapy will decrease FSH levels.

Condition Intervention
FSH Hypersecretion Endocrine System Diseases Infertility Other: CPA

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women

Resource links provided by NLM:


Further study details as provided by Clear Passage Therapies, Inc:

Primary Outcome Measures:
  • Change in endocrine levels post treatment [ Time Frame: baseline, pre-treatment and 30 and 60 days post treatment ]
    Change in FSH, LH and estradiol levels from baseline and pre-treatment, baseline and 30 and 60 day post treatment.


Secondary Outcome Measures:
  • Pain levels and sexual function before treatment [ Time Frame: 30 days before treatment ]
    Pain levels and sexual function before treatment as compared to baseline.

  • Pain levels and sexual function post treatment [ Time Frame: 30 days post treatment ]
    Pain levels and sexual function as measured by survey 30 days post treatment compared to baseline.

  • Pain levels and sexual function post treatment [ Time Frame: 60 days post treatment ]
    Pain levels and sexual function as measured by survey 60 days post treatment compared to baseline.

  • Pregnancy [ Time Frame: study duration; 60 days post treatment ]
    Subjects will be monitored for natural intrauterine pregnancy for the duration of the study.


Enrollment: 1
Study Start Date: February 2013
Study Completion Date: January 2015
Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
CPA treatment
CPA treatment group receives 20 hours of patient centered manual physical therapy
Other: CPA
Site specific, patient centered manual physical therapy regimen focused on restoring function to the entire body
Other Names:
  • Clear Passage Approach
  • Wurn Technique

Detailed Description:

This study will investigate the effect of manual physical therapy on the endocrine levels of women by comparison of pre- and post- treatment hormone levels (FSH, LH and Estradiol). Secondary measures include assessment of pain and sexual function via questionnaires.

Hormones will be measured at prescribed time points:

  • baseline: 30-60 days before treatment
  • pre-treatment: 7-30 days before treatment
  • post treatment 1: 10-30 days post treatment
  • post treatment 2: 30-60 days post treatment

Pain and sexual function questionnaires will be completed:

  • baseline: 30-60 days before treatment
  • pre-treatment: 7-30 days before treatment
  • post treatment 1: 30 days post treatment
  • post treatment 2: 60 days post treatment
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women with elevated FSH levels that undergo the CPA treatment
Criteria

Inclusion Criteria:

  • Diagnosed as infertile
  • FSH greater than 10mIU/mL on days 2-5 of menstrual cycle
  • Regular menstrual cycle
  • Residing in the US, accessible to a LabCorp testing facility

Exclusion Criteria:

  • Active infection including HIV or inflammation
  • Cancer within the past 5 years
  • Currently pregnant
  • Hemophilia, abnormal bleeding or clotting disorder
  • Immune system disorder
  • Abnormal ovarian cyst or endometrioma
  • BMI of 35 or greater
  • Any other condition in which deep manual physical therapy is contraindicated
  • Currently taking any fertility medications or planning to take any fertility related medications during the course of the study. This includes all ovarian stimulating medications, artificial hormones and birth control medications.
  • Participation in any assisted reproductive technique (such as IVF) other than intra-uterine insemination during the course of the study.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02027168


Locations
United States, Florida
Clear Passage Physical Therapy
Gainesville, Florida, United States, 32606
Sponsors and Collaborators
Clear Passage Therapies, Inc
Investigators
Principal Investigator: Lawrence J Wurn, LMT Clear Passage Physical Therapy
  More Information

Additional Information:
Publications:
Responsible Party: Clear Passage Therapies, Inc
ClinicalTrials.gov Identifier: NCT02027168     History of Changes
Other Study ID Numbers: FSH-2012-001
First Submitted: January 2, 2014
First Posted: January 6, 2014
Last Update Posted: January 26, 2015
Last Verified: January 2015

Keywords provided by Clear Passage Therapies, Inc:
infertility
elevated FSH
alternative treatment
Clear Passage Approach
Clear Passage Physical Therapy

Additional relevant MeSH terms:
Infertility
Endocrine System Diseases
Genital Diseases, Male
Genital Diseases, Female